These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7224341)

  • 1. Influence of immunosuppression on alveolar macrophage chemotactic activities in guinea pigs.
    Pennington JE; Harris EA
    Am Rev Respir Dis; 1981 Mar; 123(3):299-304. PubMed ID: 7224341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of cyclophosphamide and cortisone acetate on bronchoalveolar phagocytic cell populations.
    Pennington JE
    Am Rev Respir Dis; 1978 Aug; 118(2):319-24. PubMed ID: 697182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and cortisone acetate inhibit complement biosynthesis by guinea pig bronchoalveolar macrophages.
    Pennington JE; Matthews WJ; Marino JT; Colten HR
    J Immunol; 1979 Sep; 123(3):1318-21. PubMed ID: 469252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Jan; 118(1):146-50. PubMed ID: 830745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative effects of immunosuppression on bronchoalveolar cells.
    Pennington JE
    J Infect Dis; 1977 Jul; 136(1):127-31. PubMed ID: 886202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effect of glucocorticosteroids on pulmonary defenses in a steroid-resistant host.
    Blackwood LL; Pennington JE
    Am Rev Respir Dis; 1982 Dec; 126(6):1045-9. PubMed ID: 6983845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar macrophage subpopulations' responsiveness to chemotactic stimuli.
    Brannen AL; Chandler DB
    Am J Pathol; 1988 Jul; 132(1):161-6. PubMed ID: 3394797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
    Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the alveolar macrophage in pulmonary bacterial defense.
    Goldstein E; Bartlema HC
    Bull Eur Physiopathol Respir; 1977; 13(1):57-67. PubMed ID: 321054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic and mitogenic components of the alveolar macrophage response to particles ad neutrophil chemoattractant.
    Adamson IY; Bowden DH
    Am J Pathol; 1982 Oct; 109(1):71-7. PubMed ID: 7124909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cortisone treatment and burn injury on plasma and lung lavage cortisol concentrations and alveolar macrophage activity.
    Gudewicz PW; Ferguson JL; Kapin MA; Jaffe RC
    Adv Shock Res; 1981; 5():123-32. PubMed ID: 7304325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages.
    Hunninghake GW; Gallin JI; Fauci AS
    Am Rev Respir Dis; 1978 Jan; 117(1):15-23. PubMed ID: 619716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function.
    Hunninghake GW; Fauci AS
    Clin Exp Immunol; 1977 Mar; 27(3):555-9. PubMed ID: 862243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
    Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
    Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.
    Hunninghake GW; Gadek JE; Fales HM; Crystal RG
    J Clin Invest; 1980 Sep; 66(3):473-83. PubMed ID: 6995485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of a chemotactic factor receptor on macrophages.
    Snyderman R; Fudman EJ
    J Immunol; 1980 Jun; 124(6):2754-7. PubMed ID: 7373048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute experimental silicosis. Lung morphology, histology, and macrophage chemotaxin secretion.
    Lugano EM; Dauber JH; Daniele RP
    Am J Pathol; 1982 Oct; 109(1):27-36. PubMed ID: 7124906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation.
    Demarest GB; Hudson LD; Altman LC
    Am Rev Respir Dis; 1979 Feb; 119(2):279-86. PubMed ID: 434600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.